EUVIMEDDécouvrir EUVIMED
Crossref

Low‐Volume Plasma Exchange Following Double Plasma Molecular Adsorption System in Acute‐On‐Chronic Liver Failure: A Plasma‐Sparing Strategy

Xujia Chen iD, Linna Yu, Yun Huang, Lifang Zhou, Feng Zhang iD, Rui Ding, Ying Yao, Rong Qin iD, Hui Wang

Journal of Clinical Apheresis · 2026-06 · 41 (3)

DOI: 10.1002/jca.70144 ↗

At a glance

Journal article in Journal of Clinical Apheresis, published online on 2026-06-11. Written by Xujia Chen and 8 co-authors. Institution: Department of Gastroenterology, The Affiliated Yan'an Hospital of Kunming Medical University, Kunming, China. Major MEDLINE topics: Plasma Exchange, Acute-On-Chronic Liver Failure. 34 references. Funded by: Beijing iGandan Foundation, Yunnan Province Xingdian Talent Support Program for Medical and Health Professionals, Department of Science and Technology of Yunnan Province Kunming Medical University.

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Acute‐on‐chronic liver failure (ACLF) is associated with significant morbidity and mortality. Plasma exchange (PE) is a primary intervention for toxin removal and the management of coagulopathy. Persistent global plasma shortages highlight the urgent need to develop and implement plasma‐sparing strategies that preserve therapeutic efficacy and safety. This retrospective cohort study was conducted on 134 patients at the Department of Gastroenterology, Yan'an Hospital of Kunming, from January 2022 to December 2024. Patients were diagnosed according to the guidelines of the Chinese Medical Association. All patients received DPMAS sequential PE and were assigned to two groups according to the volume of fresh frozen plasma: the low‐volume (600–800 mL) plasma group (DPMAS + LVP group, n = 76) and the half‐volume (1000–1200 mL) plasma group (DPMAS + HVP group, n = 58). The primary outcome was 28‐day transplant‐free survival, while secondary outcomes included liver function, coagulation parameters, hematologic parameters, plasma consumption, hospitalization costs, and adverse events. The total bilirubin, serum aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, γ‐glutamyl transferase, serum ammonia, coagulation profiles including prothrombin time activity, international normalized ratio, reaction time, maximum amplitude, and clinical severity scores (MELD‐Na, CLIF‐SOFA, and AARC‐ACLF score) showed significant improvement in both groups ( p < 0.05). No significant differences were observed between groups in bilirubin reduction ( p = 0.695), coagulation profiles, hematologic parameters (all p > 0.05), or 28‐day survival rate (74% vs. 76%, p = 0.92). The DPMAS + LVP group achieved 40% plasma conservation (539 mL vs. 1050 mL) and reduced hospitalization costs (51 632 CNY vs. 67 152 CNY), compared to the HVP group ( p < 0.05). Adverse events were comparable in the DPMAS + HVP group and the DPMAS + LVP group (all p > 0.05). Multivariate analysis identified baseline MELD‐Na as an independent predictor of mortality (OR 1.13 per point, 95% CI 1.03 to 1.23, p = 0.012), while PE volume was not significantly associated with mortality (adjusted OR for HVP 2.06, p = 0.271). DPMAS sequential LVP is a feasible and resource‐efficient strategy with comparable short‐term efficacy and a favorable safety profile compared to HVP. Prospective studies are needed to validate these results.

Subjects

MeSH terms (MEDLINE)

Plasma ExchangeAcute-On-Chronic Liver FailureHumansRetrospective StudiesMaleAdsorptionFemaleMiddle AgedPlasmaAdult

Author keywords

acute on chronic liver failureartificial liver support systemsdouble plasma molecular adsorption systemplasma exchangetransplant‐free survival

Authors and institutions

  • Department of Gastroenterology, The Affiliated Yan'an Hospital of Kunming Medical University, Kunming, China.
  • Key Laboratory of Tumor Immunological Prevention and Treatment of Yunnan Province, Kunming, China.
  • Department of Gastroenterology, The First People's Hospital of Yunnan Province, Kunming, China.
  • The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.

ORCID profiles: Xujia Chen, Feng Zhang, Rong Qin

Funding

  • Beijing iGandan Foundation
  • Yunnan Province Xingdian Talent Support Program for Medical and Health Professionals
  • Department of Science and Technology of Yunnan Province Kunming Medical University
  • Health Research Project of Kunming Municipal Health Commission
  • Kunming Health Science and Technology Personnel Training Pro
  • Kunming Health Science and Technology Personnel Training Project-Medical Science and Technology Leader Personnel Training Project-Leading Talents in Medical Sc…
  • Yunnan Provincial Education Department Scientific Research Fund

Cite

APA

Chen, X., Yu, L., Huang, Y., Zhou, L., Zhang, F., Ding, R., Yao, Y., Qin, R., & Wang, H. (2026). Low‐Volume Plasma Exchange Following Double Plasma Molecular Adsorption System in Acute‐On‐Chronic Liver Failure: A Plasma‐Sparing Strategy. Journal of Clinical Apheresis, 41(3). https://doi.org/10.1002/jca.70144

Vancouver

Chen X, Yu L, Huang Y, Zhou L, Zhang F, Ding R, et al. Low‐Volume Plasma Exchange Following Double Plasma Molecular Adsorption System in Acute‐On‐Chronic Liver Failure: A Plasma‐Sparing Strategy. Journal of Clinical Apheresis. 2026;41(3). doi:10.1002/jca.70144

BibTeX
@article{Chen2026,
  author = {Chen, Xujia and Yu, Linna and Huang, Yun and Zhou, Lifang and Zhang, Feng and Ding, Rui and Yao, Ying and Qin, Rong and Wang, Hui},
  title = {Low‐Volume Plasma Exchange Following Double Plasma Molecular Adsorption System in Acute‐On‐Chronic Liver Failure: A Plasma‐Sparing Strategy},
  journal = {Journal of Clinical Apheresis},
  year = {2026},
  volume = {41},
  number = {3},
  doi = {10.1002/jca.70144}
}
Start for free →